Enalees develops molecular diagnostic tests for pets that can be used directly by veterinarians.
Enalees has raised $16.3M in total funding. The most recent round was Series A. The last funding was announced in July 2024.
Enalees's investors include Bpifrance.
Enalees is headquartered in Évry, France.
Enalees develops molecular diagnostic tests for pets that can be used directly by veterinarians.
Enalees is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enalees — Funding & Investors." VCBacked, July 27, 2024, https://www.vcbacked.co/company/enalees. Accessed July 23, 2026.
VCBacked. (2024). Enalees — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/enalees
{{cite web |title=Enalees — Funding & Investors |url=https://www.vcbacked.co/company/enalees |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated